FIELD: medicine, phthisiology.
SUBSTANCE: one should introduce by inhalation a preparation containing the mixture of rifampicin and polyvinylpyrrolidone at 1 : (3-9) ratio. The present innovation increases efficiency of therapy at applying minimal dosages of rifampicin, the action of which is increased due to combination with polyvinylpyrrolidone at certain ratio.
EFFECT: higher efficiency of therapy.
3 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
| COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
| METHOD FOR TREATING ACUTE MILIARY PULMONARY TUBERCULOSIS | 1999 |
|
RU2188034C2 |
| METHOD FOR TREATING THE CASES OF EXPERIMENTAL TUBERCULOSIS | 2000 |
|
RU2165761C1 |
| RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
| METHOD FOR TREATMENT OF BRUCELLOSIS | 2002 |
|
RU2239416C2 |
| AGENT FOR DISEASES CAUSED BY MYCOBACTERIA OF Ungernia victoris UV-22 CALLUS CULTURE STRAIN - PRODUCER OF BIOLOGICALLY ACTIVE COMPLEX FOR TREATING DISEASES CAUSED BY MYCOBACTERIA AND CULTIVATION TECHNIQUE (VERSIONS) | 2009 |
|
RU2425687C2 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| METHOD FOR TREATING TUBERCULOSIS | 2004 |
|
RU2269346C1 |
| METHOD OF TREATING EXPERIMENTAL TUBERCULOSIS IN ANIMALS | 2006 |
|
RU2391397C2 |
